Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study-Reference-Cited by-同舟云学术

Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study

Published:2023-09 Issue:5 Volume:49 Page:101465
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Peng Zi-Yang,Wang Yao-Tseng,Chang Chin-Sung,Wu Chih-Hsing,Ou Huang-Tz^ORCID

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference49 articles.

1. Risk of low-energy fracture in type 2 diabetes patients: a meta-analysis of observational studies;Jia;Osteoporos Int,2017

2. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis;Moayeri;Ther Clin Risk Manag,2017

3. Diabetes mellitus is a risk factor for low bone mass-related fractures: A meta-analysis of cohort studies;Ni;Medicine (Baltimore),2017

4. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties;Picke;Endocr Connect,2019

5. Type 2 diabetes mellitus and fracture risk;Dede;Metabolism,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complex actions of sodium glucose transporter-2 inhibitors on lipids, calcific atherosclerosis, and bone density;Current Opinion in Lipidology;2024-07-18

2. Key results from observational studies and real‐world evidence of sodium‐glucose cotransporter‐2 inhibitor effectiveness and safety in reducing cardio‐renal risk;Diabetes, Obesity and Metabolism;2024-06-10